Two Flavonoid-Based Compounds from Murraya paniculata as Novel Human Carbonic Anhydrase Isozyme II Inhibitors Detected by a Resazurin Yeast-Based Assay

키워드

참고문헌 (63)

1. Song P, "National and subnational prevalence and burden of glaucoma in China : a systematic analysis", J. Glob. Health, 7, pp.020705~ (2017)
2. Liang YB, "Proposing new indicators for glaucoma healthcare service", Eye Vis. (Lond), 4, pp.6~ (2017)
3. Varma R, "An assessment of the health and economic burdens of glaucoma", Am. J. Ophthalmol, 152, pp.515~522 (2011)
4. Goel M, "Aqueous humor dynamics : a review", Open Ophthalmol. J, 4, pp.52~59 (2010)
5. Sly WS, "Human carbonic anhydrases and carbonic anhydrase deficiencies", Annu. Rev. Biochem, 64, pp.375~401 (1995)
6. Supuran CT, "Carbonic anhydrases : novel therapeutic applications for inhibitors and activators", Nat. Rev. Drug Discov, 7, pp.168~181 (2008)
7. Supuran CT, "Carbonic anhydrase inhibitors and their therapeutic potential", Expert Opin. Ther. Pat, 10, pp.575~600 (2000)
8. Silver LH, "Clinical efficacy and safety of brinzolamide(Azopt), a new topical carbonic anhydrase inhibitor for primary openangle glaucoma and ocular hypertension", Am. J. Ophthalmol, 126, pp.400~408 (1998)
9. Scozzafava A, "Glaucoma and the applications of carbonic anhydrase inhibitors", Subcell Biochem, 75, pp.349~359 (2014)
10. Schmidl D, "Pharmacotherapy of glaucoma", J. Ocul. Pharmacol. Ther, 31, pp.63~77 (2015)
11. Kelly TE, "Acetazolamide and sulfonamide allergy : a not so simple story", High Alt. Med. Biol, 11, pp.319~323 (2010)
12. Guedes GB, "Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors", J. Ocul. Pharmacol. Ther, 29, pp.456~461 (2013)
13. Macy E, "Self-reported antibiotic allergy incidence and prevalence : age and sex effects", Am. J. Med, 122, pp.778 e771~778 e777 (2009)
14. Lomelino C, "Non-classical inhibition of carbonic anhydrase", Int. J. Mol. Sci, 17, pp.1150~ (2016)
15. Bilsland E, "Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds", Open Biol, 3, pp.120158~ (2013)
16. Barberis A, "Yeast as a screening tool", Drug Discov. Today Technol, 2, pp.187~192 (2005)
17. Ann Bjornsti M, "Cancer therapeutics in yeast", Cancer Cell, 2, pp.267~273 (2002)
18. Sangkaew A, "Development of a high throughput yeast-based screening assay for human carbonic anhydrase isozyme II inhibitors", AMB Express, 8, pp.124~ (2018)
19. Li R, "Natural Product-Based Drug Discovery", Med. Res. Rev, 36, pp.3~ (2016)
20. J. Mabberley D, "The typification of Murraya, M. exotica, and M. paniculata (Rutaceae): its significance for the world citrus industry", Taxon, 65, pp.366~371 (2016)
21. Ito C, "Constituents of Murraya exotica L. structure elucidation of new coumarins", Chem. Pharm. Bull (Tokyo), 35, pp.4277~4285 (1987)
22. Barik BR, "Coumarins of Murraya exotica—absolute configuration of auraptenol", Phytochemistry, 22, pp.792~794 (1983)
23. Shan J, "Studies on flavonoids from leaves of Murraya panaculata L. (I)", Chin Pharm. J., 45, pp.1910~1912 (2010)
24. Zhang Y, "Polymethoxylated flavonoids from the leaves of Murraya paniculata", Chin. Pharm. J, 45, pp.1139~1141 (2010)
25. Chen C-H, "Antioxidant Activity of Some Plant Extracts Towards Xanthine Oxidase, Lipoxygenase and Tyrosinase", Molecules, 14, pp.2947~2958 (2009)
26. Gautam M, "In-vitro Antioxidant properties of Murraya paniculata (L.) leaves extract", Ethnopharmacology, 2012, pp.1~3 (2012)
27. Saeed S, "Paniculacin, a new coumarin derivative from Murraya paniculata", J. Asian Nat. Prod Res, 13, pp.724~727 (2011)
28. Gautam M, "Toxicological evaluation of Murraya paniculata (L.) leaves extract on rodents", AJPT, 7, pp.62~67 (2012)
29. Gautam M, "In-vitro antibacterial activity on human pathogens and total phenolic, flavonoid contents of Murraya paniculata Linn. leaves", Asian Pac. J. Trop Biomed., 2, pp.S1660~S1663 (2012)
30. Menezes IR, "Chemical composition and evaluation of acute toxicological, antimicrobial and modulatory resistance of the extract of Murraya paniculata", Pharm. Biol, 53, pp.185~191 (2015)
31. Rodanant P, "Coumarins and flavonoid from Murraya paniculata (L.) Jack:antibacterial and anti-inflammation activity", Pak J. Pharm. Sci., 28, pp.1947~1951 (2015)
32. Lv H-N, "Anti-inflammatory coumarin and benzocoumarin derivatives from Murraya alata", J. Nat. Prod, 78, pp.279~285 (2015)
33. Davis RA, "Natural product coumarins that inhibit human carbonic anhydrases", Bioorgan. Med. Chem, 21, pp.1539~1543 (2013)
34. Karatas MO, "New coumarin derivatives as carbonic anhydrase inhibitors", Artif. Cells Nanomed. Biotechnol, 42, pp.192~198 (2014)
35. Pustenko A, "3H-1, 2-benzoxathiepine 2, 2-dioxides : a new class of isoform-selective carbonic anhydrase inhibitors", J. Enzyme. Inhib. Med. Chem, 32, pp.767~775 (2017)
36. Karatas MO, "Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors : synthesis, molecular docking and anticonvulsant studies", J. Enzyme. Inhib. Med. Chem, 31, pp.760~772 (2016)
37. Huyut Z, "Inhibition properties of some flavonoids on carbonic anhydrase I and II isoenzymes purified from human erythrocytes", J. Biochem. Mol. Toxicol, 31, pp.e21930~ (2017)
38. Ekinci D, "Carbonic anhydrase inhibitors : in vitro inhibition of alpha isoforms(hCA I, hCA II, bCA III, hCA IV)by flavonoids", J. Enzyme Inhib. Med. Chem., 28, pp.283~288 (2013)
39. Rarey M, "A fast flexible docking method using an incremental construction algorithm", J. Mol. Biol, 261, pp.470~489 (1996)
40. Grosdidier A, "SwissDock, a protein-small molecule docking web service based on EADock DSS", Nucleic Acids Res, 39, pp.W270~W277 (2011)
41. Petersson GA, "Calibration and comparison of the Gaussian-2, complete basis set, and density functional methods for computational thermochemistry", J. Chem. Phys, 109, pp.10570~10579 (1998)
42. Grosdidier A, "EADock : docking of small molecules into protein active sites with a multiobjective evolutionary optimization", Proteins, 67, pp.1010~1025 (2007)
43. Barken FM, "Excitability of a penicillin-induced cortical epileptic focus", Exp. Neurol, 70, pp.539~547 (1980)
44. Pettersen EF, "UCSF chimera-A visualization system for exploratory research and analysis", J. Comput. Chem, 25, pp.1605~1612 (2004)
45. Zhong HA, "ADME and toxicity in early drug discovery", Curr. Top Med. Chem, 13, pp.1255~1256 (2013)
46. Aguilera J, "Carbonic anhydrase(Nce103p) : an essential biosynthetic enzyme for growth of Saccharomyces cerevisiae at atmospheric carbon dioxide pressure", Biochem. J, 391, pp.311~316 (2005)
47. Polat MF, "In vitro esterase activity of carbonic anhydrase on total esterase activity level in serum", Turk J. Med. Sci, 32, pp.299~302 (2002)
48. Balaydin HT, "Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds", J. Enzyme Inhib. Med. Chem, 27, pp.467~475 (2012)
49. Ghorab MM, "Carbonic anhydrase inhibitors : synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties", Bioorg. Med. Chem, 22, pp.3684~3695 (2014)
50. Abuelizz H, "Molecular docking and anticonvulsant activity of newly synthesized quinazoline derivatives", Molecules, 22, pp.1094~ (2017)
51. Sethi KK, "Carbonic anhydrase inhibitors : synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4-and 3-nitrophthalimide moieties", Bioorg. Med. Chem, 22, pp.1586~1595 (2014)
52. Durdagi S, "Kinetic and docking studies of cytosolic", tumor-associated carbonic anhydrase isozymes I, II and IX with some hydroxylic compounds, 2016, pp.31, 1214~1220
53. Ekhteiari Salmas R, "Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II", J. Enzyme Inhib. Med. Chem, 31, pp.31~37 (2016)
54. Kinoshita T, "Isolation and structure elucidation of a new prenylcoumarin from Murraya paniculata var. omphalocarpa (Rutaceae)", Chem. Pharm. Bull (Tokyo), 50, pp.118~120 (2002)
55. Xin-Jia Y, "A New biphenyl neolignan from Leaves of Patrinia villosa (Thunb.) Juss", Pharmacogn. Mag., 12, pp.1~3 (2016)
56. Kinoshita T, "The isolation of a prenylcoumarin of chemotaxonomic significance from Murraya paniculata var. omphalocarpa", Phytochemistry, 43, pp.125~128 (1996)
57. Nour AMM, "The antiprotozoal activity of methylated flavonoids from Ageratum conyzoides L", J. Ethnopharmacol, 129, pp.127~130 (2010)
58. Tantishaiyakul V, "Phebalosin from the bark of Micromelum minutum", J. Nat. Prod, 49, pp.180~181 (1986)
59. Ferracin RJ, "Flavonoids from the fruits of Murraya paniculata", Phytochemistry, 47, pp.393~396 (1998)
60. Longhuo Wu JL, "Chondroprotective evaluation of two natural coumarins : murrangatin and murracarpin", J. Intercult. Ethnopharmacol, 2, pp.91~98 (2013)
61. Kinoshita T, "Myricetin 5, 7, 3’, 4’, 5’-pentamethyl ether and other methylated flavonoids from Murraya paniculata", Phytochemistry, 45, pp.179~181 (1997)
62. Karioti A, "New natural product carbonic anhydrase inhibitors incorporating phenol moieties", Bioorg. Med. Chem, 23, pp.7219~7225 (2015)
63. Wu T-S, "Coumarins of the flowers of Murraya paniculata", Phytochemistry, 28, pp.293~294 (1989)

관련 논문AI추천